Cancer Rop Co. Ltd. Cash Flow Reinvestment Rate

Latest as of December 2022: 4.66x

Cancer Rop Co. Ltd. cash flow reinvestment rate. Cancer Rop Co. Ltd. (180400) has a Cash Flow Reinvestment Rate of 4.66x as of December 2022, reinvesting ₩4.03 Billion (capex ₩1.74 Billion plus investments ₩2.30 Billion) from operating cash flow of ₩865.55 Million. See Cancer Rop Co. Ltd. free cash flow to debt ratio to measure the company's free cash flow as a share of total liabilities.

Reinvestment Rate

4.66x
(Capex + Investments) / Operating CF

Total Reinvested

₩4.03 Billion
Capex + Investments

Operating Cash Flow

₩865.55 Million
KRW

Capital Expenditures

₩1.74 Billion
KRW

Cash Flow Reinvestment Rate of Cancer Rop Co. Ltd. (2014–2022)

Cash flow reinvestment rate of Cancer Rop Co. Ltd. from 2014 to 2022. Historical reinvestment intensity for Cancer Rop Co. Ltd. across 2 annual periods. Explore cash flow to debt ratio of Cancer Rop Co. Ltd. to assess how comfortably operating cash covers total debt obligations.

Cancer Rop Co. Ltd. Cash Flow Reinvestment Rate by Year (2014–2022)

Cancer Rop Co. Ltd. cash flow reinvestment rate by year from 2014 to 2022. Year-by-year capital reinvestment analysis for Cancer Rop Co. Ltd.. For the full cash flow conversion analysis, see cash flow conversion of Cancer Rop Co. Ltd..

Year Reinvestment Rate Total Reinvested (KRW) Operating CF Capex YoY Change
2022 4.66x ₩4.03 Billion ₩865.55 Million ₩1.74 Billion ▲ +1015.3%
2014 0.42x ₩327.62 Million ₩783.83 Million ₩316.72 Million —
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow